Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Connors

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of STD & AIDS|June 21, 2017
Healthcare contacts among patients lost to follow-up in HIV care: review of a large regional cohort utilizing electronic health recordsWilliam J Connors, Hartmut B Krentz, M John Gill
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A ReportJollee St Fung, Victoria J Cook, James Johnston, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western CanadaPaige Muir, Victoria J Cook, Inna Sekirov, et al.
BMC Infectious Diseases|January 31, 2019
Program-wide review and follow-up of erythema Induratum of Bazin and tuberculosis-associated ocular inflammation management in a TB low-incidence setting: need for improved treatment candidate selection, therapy standardization, and care collaborationWilliam J Connors, Dina A Fisher, Dennis Y Kunimoto, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|May 14, 2026
Off-label use of dalbavancin to improve treatment outcomes and reduce health care costs in people who use drugs: A Canadian single-centre quality improvement initiativeAdrianna N Gunton, Mara Pavan, Victor Leung, et al.
BMC Infectious Diseases|March 11, 2017
Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implicationsWilliam J Connors, Heidi H Rabie, Rafael L Figueiredo, et al.
Harm Reduction Journal|November 24, 2022
Self-injecting non-prescribed substances into vascular access devices: a case study of one health system's ongoing journey from clinical concern to practice and policy responseJocelyn Chase, Melissa Nicholson, Elizabeth Dogherty, et al.
The Canadian Journal of Cardiology|November 23, 2025
Management of Infective Endocarditis Secondary to Injection Drug Use: Practical Recommendations for Clinicians From a Canadian Working GroupBenjamin T Leis, Mahee Cote, William J Connors, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of STD & AIDS|June 21, 2017
Healthcare contacts among patients lost to follow-up in HIV care: review of a large regional cohort utilizing electronic health recordsWilliam J Connors, Hartmut B Krentz, M John Gill
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A ReportJollee St Fung, Victoria J Cook, James Johnston, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western CanadaPaige Muir, Victoria J Cook, Inna Sekirov, et al.
BMC Infectious Diseases|January 31, 2019
Program-wide review and follow-up of erythema Induratum of Bazin and tuberculosis-associated ocular inflammation management in a TB low-incidence setting: need for improved treatment candidate selection, therapy standardization, and care collaborationWilliam J Connors, Dina A Fisher, Dennis Y Kunimoto, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|May 14, 2026
Off-label use of dalbavancin to improve treatment outcomes and reduce health care costs in people who use drugs: A Canadian single-centre quality improvement initiativeAdrianna N Gunton, Mara Pavan, Victor Leung, et al.
BMC Infectious Diseases|March 11, 2017
Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implicationsWilliam J Connors, Heidi H Rabie, Rafael L Figueiredo, et al.
Harm Reduction Journal|November 24, 2022
Self-injecting non-prescribed substances into vascular access devices: a case study of one health system's ongoing journey from clinical concern to practice and policy responseJocelyn Chase, Melissa Nicholson, Elizabeth Dogherty, et al.
The Canadian Journal of Cardiology|November 23, 2025
Management of Infective Endocarditis Secondary to Injection Drug Use: Practical Recommendations for Clinicians From a Canadian Working GroupBenjamin T Leis, Mahee Cote, William J Connors, et al.
Pageof 1